The metabolic syndrome and stroke: potential treatment approaches.
Arenillas
Juan F
JF
Stroke Unit, Department of Neurosciences, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Moro
María A
MA
Dávalos
Antoni
A
D050197:Atherosclerosis / Q000503:physiopathology; D002545:Brain Ischemia / Q000188:drug therapy; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D008928:Mitochondria / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use; D047495:PPAR gamma / Q000378:metabolism; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy*; D045162:Thiazolidinediones / Q000627:therapeutic use; D014157:Transcription Factors / Q000378:metabolism; D016896:Treatment Outcome
D016207:Cytokines; D018696:Neuroprotective Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D014157:Transcription Factors